                               SEQUENCE LISTING	

<110> SCHRUM, JASON
 
<120> MODIFIED NUCLEOSIDES, NUCLOETIDES, AND NUCLEIC ACIDS, AND USES 
      THEREOF

<130> M2107-7008WO

<140> PCT/US2011/054617
<141> 2011-10-03

<150> 61/404,413
<151> 2010-10-01

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 852
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
agcttttgga ccctcgtaca gaagctaata cgactcacta tagggaaata agagagaaaa       60

gaagagtaag aagaaatata agagccacca tggccggtcc cgcgacccaa agccccatga      120

aacttatggc cctgcagttg ctgctttggc actcggccct ctggacagtc caagaagcga      180

ctcctctcgg acctgcctca tcgttgccgc agtcattcct tttgaagtgt ctggagcagg      240

tgcgaaagat tcagggcgat ggagccgcac tccaagagaa gctctgcgcg acatacaaac      300

tttgccatcc cgaggagctc gtactgctcg ggcacagctt ggggattccc tgggctcctc      360

tctcgtcctg tccgtcgcag gctttgcagt tggcagggtg cctttcccag ctccactccg      420

gtttgttctt gtatcaggga ctgctgcaag cccttgaggg aatctcgcca gaattgggcc      480

cgacgctgga cacgttgcag ctcgacgtgg cggatttcgc aacaaccatc tggcagcaga      540

tggaggaact ggggatggca cccgcgctgc agcccacgca gggggcaatg ccggcctttg      600

cgtccgcgtt tcagcgcagg gcgggtggag tcctcgtagc gagccacctt caatcatttt      660

tggaagtctc gtaccgggtg ctgagacatc ttgcgcagcc gtgaagcgct gccttctgcg      720

gggcttgcct tctggccatg cccttcttct ctcccttgca cctgtacctc ttggtctttg      780

aataaagcct gagtaggaag gcggccgctc gagcatgcat ctagagggcc caattcgccc      840

tattcgaagt cg                                                          852


<210> 2
<211> 852
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 2
agcuuuugga cccucguaca gaagcuaaua cgacucacua uagggaaaua agagagaaaa       60

gaagaguaag aagaaauaua agagccacca uggccggucc cgcgacccaa agccccauga      120

aacuuauggc ccugcaguug cugcuuuggc acucggcccu cuggacaguc caagaagcga      180

cuccucucgg accugccuca ucguugccgc agucauuccu uuugaagugu cuggagcagg      240

ugcgaaagau ucagggcgau ggagccgcac uccaagagaa gcucugcgcg acauacaaac      300

uuugccaucc cgaggagcuc guacugcucg ggcacagcuu ggggauuccc ugggcuccuc      360

ucucguccug uccgucgcag gcuuugcagu uggcagggug ccuuucccag cuccacuccg      420

guuuguucuu guaucaggga cugcugcaag cccuugaggg aaucucgcca gaauugggcc      480

cgacgcugga cacguugcag cucgacgugg cggauuucgc aacaaccauc uggcagcaga      540

uggaggaacu ggggauggca cccgcgcugc agcccacgca gggggcaaug ccggccuuug      600

cguccgcguu ucagcgcagg gcggguggag uccucguagc gagccaccuu caaucauuuu      660

uggaagucuc guaccgggug cugagacauc uugcgcagcc gugaagcgcu gccuucugcg      720

gggcuugccu ucuggccaug cccuucuucu cucccuugca ccuguaccuc uuggucuuug      780

aauaaagccu gaguaggaag gcggccgcuc gagcaugcau cuagagggcc caauucgccc      840

uauucgaagu cg                                                          852


<210> 3
<211> 207
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Met Ala Gly Pro Ala Thr Gln Ser Pro Met Lys Leu Met Ala Leu Gln 
1               5                   10                  15      


Leu Leu Leu Trp His Ser Ala Leu Trp Thr Val Gln Glu Ala Thr Pro 
            20                  25                  30          


Leu Gly Pro Ala Ser Ser Leu Pro Gln Ser Phe Leu Leu Lys Cys Leu 
        35                  40                  45              


Glu Gln Val Arg Lys Ile Gln Gly Asp Gly Ala Ala Leu Gln Glu Lys 
    50                  55                  60                  


Leu Val Ser Glu Cys Ala Thr Tyr Lys Leu Cys His Pro Glu Glu Leu 
65                  70                  75                  80  


Val Leu Leu Gly His Ser Leu Gly Ile Pro Trp Ala Pro Leu Ser Ser 
                85                  90                  95      


Cys Pro Ser Gln Ala Leu Gln Leu Ala Gly Cys Leu Ser Gln Leu His 
            100                 105                 110         


Ser Gly Leu Phe Leu Tyr Gln Gly Leu Leu Gln Ala Leu Glu Gly Ile 
        115                 120                 125             


Ser Pro Glu Leu Gly Pro Thr Leu Asp Thr Leu Gln Leu Asp Val Ala 
    130                 135                 140                 


Asp Phe Ala Thr Thr Ile Trp Gln Gln Met Glu Glu Leu Gly Met Ala 
145                 150                 155                 160 


Pro Ala Leu Gln Pro Thr Gln Gly Ala Met Pro Ala Phe Ala Ser Ala 
                165                 170                 175     


Phe Gln Arg Arg Ala Gly Gly Val Leu Val Ala Ser His Leu Gln Ser 
            180                 185                 190         


Phe Leu Glu Val Ser Tyr Arg Val Leu Arg His Leu Ala Gln Pro 
        195                 200                 205         


<210> 4
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
ttggaccctc gtacagaagc taatacg                                           27


<210> 5
<211> 149
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt       60

tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt      120

cttcctactc aggctttatt caaagacca                                        149


<210> 6
<211> 29
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
cttcctactc aggctttatt caaagacca                                         29


<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
tggccggtcc cgcgacccaa                                                   20


<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
gcttcacggc tgcgcaagat                                                   20


